Targeting ferroptosis in hepatocellular carcinoma

被引:14
|
作者
Mo, Yuqian [1 ]
Zou, Zhilin [2 ]
Chen, Erbao [3 ]
机构
[1] Guangdong Med Univ, Sch Publ Hlth, Zhanjiang 524023, Guangdong, Peoples R China
[2] Wenzhou Med Univ, Affiliated Eye Hosp, Dept Ophthalmol, Wenzhou, Zhejiang, Peoples R China
[3] Peking Univ, Shenzhen Hosp, Dept Hepatobiliary & Pancreat Surg, Shenzhen 518036, Guangdong, Peoples R China
关键词
Ferroptosis; Hepatocellular carcinoma; Immunotherapy; Immune microenvironment; SUPPRESSOR-CELLS; LIPID-PEROXIDATION; T-CELLS; 1ST-LINE TREATMENT; CANCER; DYSFUNCTION; SORAFENIB; ZIP14; TRANSPORTER; SENSITIVITY;
D O I
10.1007/s12072-023-10593-y
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
Hepatocellular carcinoma (HCC) is a common malignant tumor with complex survival mechanism and drug resistance, resulting in cancer-related high mortality in the world. Ferroptosis represents a form of regulated cell death, typically distinguished by iron-dependent lipid peroxidation. Cancer cells often employ antioxidant defenses to evade the harmful effects of excess iron. Recent research has proposed that directing interventions towards ferroptosis could serve as an effective strategy in curbing the proliferation and invasion of HCC. Immunotherapy has made some preliminary progress in the remodeling of immune microenvironment, but it has not completely inhibited HCC growth, invasion and drug resistance. Furthermore, ferroptosis is widely observed in the formation of immune microenvironment of HCC and mediates the response of many targeted drugs and immunotherapy. Clarifying the role of ferroptosis in these complex processes is expected to provide a new prospect for HCC treatment. In this review, we outline the mechanisms by which HCC develops invasiveness and drug resistance by evading iron-dependent death, and paint a comprehensive landscape of ferroptosis in different cell types in the HCC immune microenvironment.
引用
收藏
页码:32 / 49
页数:18
相关论文
共 50 条
  • [31] Sorafenib triggers ferroptosis via inhibition of HBXIP/SCD axis in hepatocellular carcinoma
    Zhang, Lu
    Li, Xian-meng
    Shi, Xu-he
    Ye, Kai
    Fu, Xue-li
    Wang, Xue
    Guo, Shi-man
    Ma, Jia-qi
    Xu, Fei-fei
    Sun, Hui-min
    Li, Qian-qian
    Zhang, Wei-ying
    Ye, Li-hong
    ACTA PHARMACOLOGICA SINICA, 2023, 44 (03) : 622 - 634
  • [32] Brusatol induces ferroptosis to inhibit hepatocellular carcinoma progression by targeting ATF3
    Wan, Yuanyuan
    Cheng, Jingsong
    Gan, Debiao
    He, Jiaming
    Chen, An
    Ma, Jing
    Li, Yunying
    Wang, Xiao
    Ran, Jianhua
    Chen, Dilong
    Li, Jing
    CHEMICAL BIOLOGY & DRUG DESIGN, 2024, 103 (06)
  • [33] A ferroptosis-related ceRNA network in hepatocellular carcinoma for potential clinical applications
    Yang, Zelong
    He, Kun
    Chen, Weigang
    Chen, Yong
    AMERICAN JOURNAL OF TRANSLATIONAL RESEARCH, 2023, 15 (06): : 3912 - 3927
  • [34] Ferroptosis, pyroptosis and necroptosis in hepatocellular carcinoma immunotherapy: Mechanisms and immunologic landscape (Review)
    Liu, Rui-Jia
    Yu, Xu-Dong
    Yan, Shao-Shuai
    Guo, Zi-Wei
    Zao, Xiao-Bin
    Zhang, Yao-Sheng
    INTERNATIONAL JOURNAL OF ONCOLOGY, 2024, 64 (06)
  • [35] Targeting ferroptosis: the role of non-coding RNAs in hepatocellular carcinoma progression and therapy
    Wang, Weijia
    Hashimi, Behishta
    Wang, Ping
    NAUNYN-SCHMIEDEBERGS ARCHIVES OF PHARMACOLOGY, 2025, : 6335 - 6348
  • [36] Novel Insights in the Regulatory Mechanisms of Ferroptosis in Hepatocellular Carcinoma
    Ma, Shiwen
    Adzavon, Yao Mawulikplimi
    Wen, Xiaohu
    Zhao, Pengxiang
    Xie, Fei
    Liu, Mengyu
    Ma, Xuemei
    FRONTIERS IN CELL AND DEVELOPMENTAL BIOLOGY, 2022, 10
  • [37] Ferroptosis: a new hunter of hepatocellular carcinoma
    Jiang, Yulang
    Yu, Yongxin
    Pan, Ziyang
    Glandorff, Christian
    Sun, Mingyu
    CELL DEATH DISCOVERY, 2024, 10 (01)
  • [38] Targeting Angiogenesis for Advanced Hepatocellular Carcinoma
    Eso, Yuji
    INTERNAL MEDICINE, 2021, 60 (03) : 321 - 322
  • [39] The Identification and Validation of Two Heterogenous Subtypes and a Risk Signature Based on Ferroptosis in Hepatocellular Carcinoma
    Liu, Zaoqu
    Wang, Libo
    Liu, Long
    Lu, Taoyuan
    Jiao, Dechao
    Sun, Yuling
    Han, Xinwei
    FRONTIERS IN ONCOLOGY, 2021, 11
  • [40] Mitochondrial TSPO Promotes Hepatocellular Carcinoma Progression through Ferroptosis Inhibition and Immune Evasion
    Zhang, Deguo
    Man, Da
    Lu, Jiahua
    Jiang, Yifan
    Ding, Bo
    Su, Rong
    Tong, Rongliang
    Chen, Junru
    Yang, Beng
    Zheng, Shusen
    Chen, Diyu
    Wu, Jian
    ADVANCED SCIENCE, 2023, 10 (15)